# A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice

> **NCT05254366** · — · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 2022 (actual)

## Conditions studied

- Gastroscopic and Colonoscopic Sedation

## Interventions

- **DRUG:** Remimazolam Tosilate for Injection

## Key facts

- **NCT ID:** NCT05254366
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-30
- **Primary completion:** 2023-02-08
- **Final completion:** 2023-02-08
- **Target enrollment:** 2022 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254366, "A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05254366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*